CLINICAL_TRIALS
ClinicalTrials.gov record update
The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics in Patients With Type 2 Diabetes and Obesity: A Prospective, Randomized, Open-label, Active Drug Controlled Clinical Trial
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06059287
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:33.829357+00:00
- Published At
- 2023-09-28T00:00:00+00:00
- Record Updated At
- 2023-09-28
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Obesity", "Type 2 Diabetes", "Sodium-glucose Co-transporter-2 Inhibitor", "Myocardial Fibrosis", "Magnetic Resonance Imaging"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-09-28"- protocolSection.identificationModule.nctId
"NCT06059287"- protocolSection.identificationModule.officialTitle
"The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics in Patients With Type 2 Diabetes and Obesity: A Prospective, Randomized, Open-label, Active Drug Controlled Clinical Trial"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.